β3-tubulin is a good predictor of sensitivity to taxane-based neoadjuvant chemotherapy in primary breast cancer.

about

β3-tubulin is a good predictor of sensitivity to taxane-based neoadjuvant chemotherapy in primary breast cancer.

Item

http://www.wikidata.org/entity/Q53837284

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

β3-tubulin is a good predictor ...... rapy in primary breast cancer.

@en

β3-tubulin is a good predictor ...... rapy in primary breast cancer.

@nl

type

Item

label

β3-tubulin is a good predictor ...... rapy in primary breast cancer.

@en

β3-tubulin is a good predictor ...... rapy in primary breast cancer.

@nl

prefLabel

β3-tubulin is a good predictor ...... rapy in primary breast cancer.

@en

β3-tubulin is a good predictor ...... rapy in primary breast cancer.

@nl

P1476

β3-tubulin is a good predictor ...... rapy in primary breast cancer.

@en

P2093

Guilong Guo

http://www.w3.org/2001/XMLSchema#string

Huxiang Zhang

http://www.w3.org/2001/XMLSchema#string

Xiaohua Zhang

http://www.w3.org/2001/XMLSchema#string

Xiaoqu Hu

http://www.w3.org/2001/XMLSchema#string

Yifei Pan

http://www.w3.org/2001/XMLSchema#string

Yinlong Yang

http://www.w3.org/2001/XMLSchema#string

Youqun Xiang

http://www.w3.org/2001/XMLSchema#string

P2860

Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer

Class III beta-tubulin isotype predicts response in advanced breast cancer patients randomly treated either with single-agent doxorubicin or docetaxel

Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer.

Expression of class III beta-tubulin reduces microtubule assembly and confers resistance to paclitaxel.

Prospective multicenter randomized phase III study of weekly versus standard docetaxel (D2) for first-line treatment of metastatic breast cancer.

Topoisomerase II alpha and TLE3 as predictive markers of response to anthracycline and taxane-containing regimens for neoadjuvant chemotherapy in breast cancer.

Altered beta-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells

Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells.

miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer.

Neoadjuvant doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early stage breast cancer and evaluation of βIII-tubulin expression as a predictive marker.

P2888

s10238-015-0371-4

P304

391-397

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10238-015-0371-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26088183

http://www.w3.org/2001/XMLSchema#string